Targeting of PIM Kinases Shows Single Agent Efficacy and Synergizes with BCL2 Inhibitors in Diffuse Large B Cell Lymphoma of the ABC Subtype.
Hematological oncology(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined